Baskhanbio Pharma (XKON:A354390) - Stock Price, News & Analysis

A354390 Stock Overview

Provides pain medicines before and after surgery, and medical devices for surgical process in South Korea. More details

A354390 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Volatile share price over the past 3 months compared to the KR market

Does not have a meaningful market cap (₩27B)

Baskhanbio Pharma Inc. Competitors

ADBiotech

KOSDAQ:A179530

₩26.6b

WooGene B&G

KOSDAQ:A018620

₩27.5b

ChoA Pharmaceutical

KOSDAQ:A034940

₩30.1b

Union Korea Pharm

KOSDAQ:A080720

₩15.4b

Price History & Performance

Summary of all time highs, changes and price drops for Baskhanbio Pharma
Historical stock prices
Current Share Price	₩3,880.00
52 Week High	₩8,200.00
52 Week Low	₩3,400.00
Beta	0
11 Month Change	-3.96%
3 Month Change	-30.59%
1 Year Change	-36.39%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-67.12%

Recent updates

Shareholder Returns

	A354390	KR Pharmaceuticals	KR Market
7D	-3.0%	-9.2%	-2.8%
1Y	-36.4%	8.0%	-3.4%

Return vs Industry: A354390 underperformed the KR Pharmaceuticals industry which returned 8% over the past year.

Return vs Market: A354390 underperformed the KR Market which returned -3.4% over the past year.

Price Volatility

Is A354390's price volatile compared to industry and market?
A354390 volatility
A354390 Average Weekly Movement	10.3%
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A354390's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A354390's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	baskhanbio.com

Baskhanbio Pharma Inc. provides pain medicines before and after surgery, and medical devices for surgical process in South Korea. The company is based in Anseong, South Korea.

Baskhanbio Pharma Inc. Fundamentals Summary

How do Baskhanbio Pharma's earnings and revenue compare to its market cap?
A354390 fundamental statistics
Market cap	₩27.23b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A354390 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A354390 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A354390 perform over the long term?

See historical performance and comparison

Baskhanbio Pharma XKON:A354390 Stock Report